August 22, 2016 / 6:16 AM / a year ago

BRIEF-Xbrane Biopharma Q2 pre-tax loss increases to SEK 7.6 mln

Aug 22 (Reuters) - Xbrane Biopharma AB :

* Q2 net sales 1.0 million Swedish crowns ($118,822.70) versus 75,000 crowns year ago

* Q2 pre-tax loss 7.6 million crowns versus loss 1.3 million crowns year ago Source text for Eikon:

Further company coverage: ($1 = 8.4159 Swedish crowns) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below